1,541 results on '"Velazquez, Eric J."'
Search Results
202. Efficacy and Safety of Sacubitril/Valsartan in High-Risk Patients in the PIONEER-HF Trial
203. Restoring ventricular restoration: A call to re‐evaluate a surgical therapy considered ineffective
204. Clinical characteristics and referral pattern of patients with left ventricular dysfunction and significant coronary artery disease undergoing radionuclide imaging
205. Myocardial viability and impact of surgical ventricular reconstruction on outcomes of patients with severe left ventricular dysfunction undergoing coronary artery bypass surgery: Results of the Surgical Treatment for Ischemic Heart Failure trial
206. Resource use, costs, and quality of life among patients in the multinational Valsartan in Acute Myocardial Infarction Trial (VALIANT)
207. Relation between renal dysfunction and cardiovascular outcomes after myocardial infraction
208. Multinational economic evaluation of valsartan in patients with chronic heart failure: results from the valsartan hear failure trial (Val-HeFT)
209. Importance of echocardiography in patients with severe nonischemic heart failure: The second prospective randomized amlodipine survival evaluation(PRAISE-2) echocardiographic study
210. Therapy for Mental Stress–Induced Myocardial Ischemia—Reply
211. Effect of Escitalopram on Mental Stress–Induced Myocardial Ischemia: Results of the REMIT Trial
212. Effect of Phosphodiesterase-5 Inhibition on Exercise Capacity and Clinical Status in Heart Failure With Preserved Ejection Fraction: A Randomized Clinical Trial
213. Heart Failure in Sub-Saharan Africa
214. Mechanical dyssynchrony evaluated by tissue Doppler cross-correlation analysis is associated with long-term survival in patients after cardiac resynchronization therapy
215. Influence of baseline left ventricular function on the clinical outcome of surgical ventricular reconstruction in patients with ischaemic cardiomyopathy
216. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both
217. Revascularization in patients with coronary artery disease, left ventricular dysfunction, and viability: A meta-analysis
218. Radionuclide viability testing: Should it affect treatment strategy in patients with cardiomyopathy and significant coronary artery disease?
219. Ultrafiltration in Decompensated Heart Failure with Cardiorenal Syndrome
220. Epidemiology of Heart Failure and Left Ventricular Systolic Dysfunction after Acute Myocardial Infarction: Prevalence, Clinical Characteristics, and Prognostic Importance
221. Variability of Global Left Ventricular Deformation Analysis Using Vendor Dependent and Independent Two-Dimensional Speckle-Tracking Software in Adults
222. Race and gender variation in the QT interval and its association with mortality in patients with coronary artery disease: Results from the Duke Databank for Cardiovascular Disease (DDCD)
223. Core Lab Analysis of Baseline Echocardiographic Studies in the STICH Trial and Recommendation for Use of Echocardiography in Future Clinical Trials
224. Responses of mental stress-induced myocardial ischemia to escitalopram treatment: Background, design, and method for the Responses of Mental Stress Induced Myocardial Ischemia to Escitalopram Treatment trial
225. Cardiac structure and function, remodeling, and clinical outcomes among patients with diabetes after myocardial infarction complicated by left ventricular systolic dysfunction, heart failure, or both
226. CABG in Patients with Left Ventricular Dysfunction
227. Coronary-Artery Bypass Surgery in Patients with Left Ventricular Dysfunction
228. Myocardial Viability and Survival in Ischemic Left Ventricular Dysfunction
229. Diuretic Strategies in Patients with Acute Decompensated Heart Failure
230. Impact of early surgery on survival of patients with severe mitral regurgitation
231. Early impairment of myocardial deformation assessed by regional speckle-tracking echocardiography in the indeterminate form of Chagas disease without fibrosis detected by cardiac magnetic resonance
232. Limitations of Natriuretic Peptide Levels in Establishing SGLT-2 Inhibitors for Heart Failure Care
233. Cost-effectiveness of Sacubitril-Valsartan in Hospitalized Patients Who Have Heart Failure With Reduced Ejection Fraction
234. Inpatient Transthoracic Echocardiography during the COVID-19 Pandemic: Evaluating a New Triage Process
235. Left Ventricular Systolic Function and Inpatient Mortality in Patients Hospitalized with Coronavirus Disease 2019 (COVID-19)
236. Heart Failure With Preserved Ejection Fraction
237. COVID-19 infections and outcomes in a live registry of heart failure patients across an integrated health care system
238. Implications of ST Changes During Normal Echocardiography—Reply
239. Angiotensin Receptor-Neprilysin Inhibition Based on History of Heart Failure and Use of Renin-Angiotensin System Antagonists
240. Clinical Characteristics and Outcomes for 7,995 Patients with SARS-CoV-2 Infection
241. Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting to Treat Ischemic Cardiomyopathy?
242. Cardiac remodeling after large ST-elevation myocardial infarction in the current therapeutic era
243. Incremental Prognostic Value of Echocardiography of Left Ventricular Remodeling and Diastolic Function in STICH Trial
244. Implications of Abnormal Exercise Electrocardiography With Normal Stress Echocardiography
245. LIMITED TESTING FOR CORONARY ARTERY DISEASE IN PATIENTS WITH NEW-ONSET HEART FAILURE: FINDINGS FROM GET WITH THE GUIDELINES - HEART FAILURE
246. Contributors
247. Surgical Treatment of Heart Failure
248. PROspective Multicenter Imaging Study for Evaluation of chest pain: Rationale and design of the PROMISE trial
249. The inter-relationship of diabetes and left ventricular systolic function on outcome after high-risk myocardial infarction
250. The STICH trial: evidence-based conclusions
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.